Article
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
26 May 2015
Abstract excerpt
Serum biomarkers in Duchenne muscular dystrophy (DMD) may provide deeper insights into disease pathogenesis, suggest new therapeutic approaches, serve as acute read-outs of drug effects, and be useful as surrogate outcome measures to predict later clinical benefit. In this study a large-scale biomarker discovery was performed on serum samples from patients with DMD and age-matched healthy volunteers using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
